10 years ago: Sanofi-Aventis takeover


Aventis has finally accepted a bid from its French rival Sanofi Synthélabo, ending months of wrangling between the two companies and creating the world’s third largest pharmaceutical firm, after Pfizer and GlaxoSmithKline.
Aventis had for some time fought off a €45bn hostile bid from Sanofi, despite the fact that the French government had openly supported the takeover. The government had discouraged a ‘white knight’ bid from Swiss pharmaceutical firm Novartis, openly displaying its enthusiasm for a French national pharmaceutical champion. It also stressed the need for France to guarantee access to vaccines in the event of a terrorist attack.
The new group will be called Sanofi-Aventis, and will be headed by Jean-François Dehecq, Sanofi’s CEO.
Chemistry World (June 2004)

Ed.  Since 2004 Chemistry World has regularly reported on the fortunes of Sanofi-Aventis, which has developed into a global healthcare company, with acquisitions including Zentiva, Medley, Kendricks, Acambis, Symbion and Merial. It is the world’s largest producer of vaccines through its subsidiary Sanofi Pasteur. In 2011, Sanofi-Aventis acquired Genzyme and shareholders approved the change of company name to Sanofi at that year’s combined shareholder meeting.
 


Related Content

Sanofi hostile move for Genzyme

5 October 2010 News Archive

news image

Sanofi-Aventis makes a hostile $18.5 billion takeover bid for US biotech, Genzyme

Business roundup

28 October 2010 Business

news image

Industry news, November 2010

Most Read

Higher levels of some metals in e-cigarette smoke

8 September 2014 Research

news image

Scientists call for regulators to help clear smoke and mirrors surrounding vaping safety

Isotope effect produces new type of chemical bond

22 October 2014 Research

news image

Evidence emerges for vibrational bond first proposed 30 years ago

Most Commented

Higher levels of some metals in e-cigarette smoke

8 September 2014 Research

news image

Scientists call for regulators to help clear smoke and mirrors surrounding vaping safety

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines